Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 8 | 2500.00 | 1955.17 | 4405.00 | 4282.00 | 1.0287 | 1.0507 |
| SK-BR-3 | Linsitinib | 0.1 | uM | 8 | 2500.00 | 1955.17 | 4250.00 | 4282.00 | 0.9925 | 0.9868 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 8 | 2500.00 | 1955.17 | 2562.00 | 4282.00 | 0.5983 | 0.2700 |
| SK-BR-3 | 0 | uM | 8 | 2500.00 | 1955.17 | 4441.00 | 4282.00 | 1.0371 | 1.0655 | |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 8 | 2500.00 | 1955.17 | 4312.00 | 4282.00 | 1.0070 | 1.0124 |
| SK-BR-3 | 0 | uM | 8 | 2500.00 | 1955.17 | 4324.00 | 4282.00 | 1.0098 | 1.0173 | |
| SK-BR-3 | Linsitinib | 0.01 | uM | 8 | 2500.00 | 1955.17 | 4591.00 | 4282.00 | 1.0722 | 1.1271 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 8 | 2500.00 | 1955.17 | 1967.00 | 4282.00 | 0.4594 | 0.0053 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 8 | 2500.00 | 1955.17 | 3976.00 | 4282.00 | 0.9285 | 0.8731 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 8 | 2500.00 | 1955.17 | 2165.00 | 4282.00 | 0.5056 | 0.0943 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 8 | 2500.00 | 1955.17 | 1790.00 | 4282.00 | 0.4180 | -0.0751 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 8 | 2500.00 | 1955.17 | 4591.00 | 4282.00 | 1.0722 | 1.1271 |
| SK-BR-3 | 0 | uM | 8 | 2500.00 | 1955.17 | 4592.00 | 4282.00 | 1.0724 | 1.1275 | |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 8 | 2500.00 | 1955.17 | 2299.00 | 4282.00 | 0.5369 | 0.1540 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 8 | 2500.00 | 1955.17 | 3175.00 | 4282.00 | 0.7415 | 0.5352 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 8 | 2500.00 | 1955.17 | 4193.00 | 4282.00 | 0.9792 | 0.9632 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 8 | 2500.00 | 1955.17 | 2154.00 | 4282.00 | 0.5030 | 0.0894 |
| SK-BR-3 | 0 | uM | 8 | 2500.00 | 1955.17 | 4168.00 | 4282.00 | 0.9734 | 0.9529 | |
| SK-BR-3 | 0 | uM | 8 | 2500.00 | 1955.17 | 3947.00 | 4282.00 | 0.9218 | 0.8610 | |
| SK-BR-3 | 0 | uM | 8 | 5000.00 | 1743.19 | 6143.00 | 6184.25 | 0.9933 | 0.9927 | |
| SK-BR-3 | 0 | uM | 8 | 5000.00 | 1743.19 | 6203.00 | 6184.25 | 1.0030 | 1.0033 | |
| SK-BR-3 | Erlotinib | 0.01 | uM | 8 | 5000.00 | 1743.19 | 5854.00 | 6184.25 | 0.9466 | 0.9408 |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 8 | 5000.00 | 1743.19 | 5929.00 | 6184.25 | 0.9587 | 0.9544 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 8 | 5000.00 | 1743.19 | 6051.00 | 6184.25 | 0.9785 | 0.9763 |
| SK-BR-3 | Erlotinib | 1 | uM | 8 | 5000.00 | 1743.19 | 5663.00 | 6184.25 | 0.9157 | 0.9059 |